Comparison of 3000 IU aXa of the low molecular weight heparin Certoparin with 5000 IU aXa in prevention of deep vein thrombosis after total hip replacement

International Angiology

Volumn 18, Issue 2, 1999, Pages 122-126

  Adolf, J ^h   Fritsche, H M ^a   Haas, S ^b   Hennig, F F ^c   Horbach, T ^c   Kastl, S ^c   Koppenhagen, K ^d   Michaelis, H C ^e   Rhamanzadeh, R ^f   Summa, W ^c   Wagner, W ^g   Weber, U ^f   Wolf, H ^e  

^a Department of Surgery   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d Univ Clin Radiol and Nucl Med   (Germany)

^e NOVARTIS PHARMA GMBH   (Germany)

^f University Hospital   (Germany)

^g City Hospital   (Germany)

^h Klinikum Memmingen   (Germany)

Author keywords

Arthroplasty, replacement, hip; Heparin; Low molecular weight; Thrombophlebitis prevention and control

Indexed keywords

CERTOPARIN; LOW MOLECULAR WEIGHT HEPARIN; MONOEMBOLEX;

ADULT; AGED; ARTICLE; BLEEDING; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; FEMALE; FRACTURE; HEMATOMA; HIP OSTEOARTHRITIS; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; PAIN; POSTOPERATIVE COMPLICATION; PROSTATE ADENOMA; PROSTHESIS LOOSENING; RANDOMIZED CONTROLLED TRIAL; TOTAL HIP PROSTHESIS; URINE RETENTION; WOUND INFECTION; CONTROLLED STUDY; DOSE RESPONSE; HIP ARTHROPLASTY; LUNG EDEMA; MIDDLE AGED; PROSPECTIVE STUDY; VEIN THROMBOSIS;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEMATOMA; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY EDEMA; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 0033145141     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Adolf J, Knee H, van de Flierdt E, Sievert JR. Thromboembolieprophylaxe mit niedermolekularem Heparin in der Abdominalchirurgie. (Prevention of thromboembolism with low molecular weight heparin in abdominal surgery.) Dtsch Med Wochenschr 1989;114:48-53.
2. Koppenhagen K, Matthes M, Haring R, Troster E, Wolf H, Welzel D. Prophylaxis of thromboembolic events in abdominal surgery. Comparison of the efficacy and safety of low molecular weight heparin and unfractionated heparin. Munch Med Wochenschr 1990;132:677-80.
3. Hoffmann W. Comparative study of low molecular weight heparin versus low dose heparin. Expert study report for mareketing authorisation, 1987.
4. Kakkar W. A prospective, randomised double blind trial of low molecular weight heparin (LMWH) and unfractionated heparin (UF) in prevention of venous thrombosis. Expert study report for marketung authorisation, 1989.
5. Koppenhagen K, Adolf J, Matthes M, Troster E, Roder JD, Haas S et al. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery. Thromb Haemost 1992;67(6):627-30.
6. Kakkar W. A prospective randomized double-blind trial to assess the safety and efficacy of low molecular weight heparin and dihydroergotamine in the prevention of postoperative thromboembolic disease following hip artroplasty. Expert study report for marketing authorisation, 1989.
7. Haas S. Double-blind comparison of the efficacy and safety of low molecular weight heparin 1500 I.U. and low molecular weight heparin in fixed combination with dihydroergotamine (Embolex NM) in patients undergoing total hip replacement. Expert study report for marketing authorisation, 1989.
8. Schiag G. Thrombosis prophylaxis study. LMW Heparin and Heparin-Sintrom. Expert study report for marketing authorisation, 1989.
9. Oertli D, Hess P, Durig M, Laffer U, Fridrich R, Jaeger K et al. Prevention of deep vein thrombosis in patients with hip fractures: low molecular weight heparin versus dextran. World J Surg 1992;5(5):980-5.
10. Wolf H, Encke A, Haas S, Welzel D. Comparison of the efficacy and safety of Sandoz low molecular weight heparin and unfractionated heparin: Interim analysis of a multicenter trial. Semin Thromb Haemost 1991;17: 343-6.
11. Heilmann L, Kruck M, Schindier AE. Thromboseprophylaxe in der Gynäkologie: Doppelblind-Vergleich zwischen niedermolekularem (LMWH) und unfraktioniertem (UFH) Heparin. Geburtsh Frauenheilk 1989;49:803-7.
12. Harenberg J, Kallenbach B, Martin U, Dempfle CE, Zimmermann R, Kubler W et al. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep vein thrombosis in medical patients. Thromb Res 1990;59:639-50.
13. Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A et al. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Thromb Haemost 1996;75:246-50.
14. Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992;305:913-20.
15. Planes A, Vochelle N, Matas F, Mansat C, Zucman J, Landais A et al. Prevention of postoperative venous thrombosis: A randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988;60:407-10.
16. Turpie AGG, Levine M, Hirsh J, Carter CJ, Jay RM, Powers PJ et al. A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315:925-9.
17. Colwell CW, Spiro TE, Trowbridge M, Morris BA, Kwaan HC, Blaha JD et al. Use of enoxaparin, a low molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip surgery. J Bone Joint Surg 1994;76:3-14.
18. Planes A, Vochelle N, Ferru J, Przyrowski D, Clerc J, Fagola M et al. Enoxaparine low molecular weight heparin: Its use in the prevention of deep vein thrombosis following total hip replacement. Haemostasis 1986;16:152-8.
19. Planes A, Vochelle N, Fagola M, Feret J, Bellaud M. Prevention of deep vein thrombosis after total hip replacement. J Bone Joint Surg 1991;73:418-22.
20. Leyvraz PF, Bachmann F, Hoek J, Büller HR, Samama M, Vandenbroek MD. Prevention of deep vein thrombosis after hip replacement: Randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ 1991;303:543-8.